Skip to main content

Future Directions for Clinical Research

  • Chapter
Inflammatory Bowel Diseases 1986

Part of the book series: Developments in Gastroenterology ((DIGA,volume 8))

  • 45 Accesses

Abstract

To see into the future, we should begin with a glance at the past. Just four years ago, at the First International IBD Symposium in Jerusalem, Dr. Kirsner, Mr. Alexander-Williams, and I stood on this very platform and offered some predictions, if not prescriptions, concerning “New Directions for Future Research.” How have our predictions fared in the light of today, and how should we revise them for tomorrow?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Donowitz M. Arachidonic acid metabolites and their role in inflammatory bowel disease. Gastroenterology 1985; 88: 580–7.

    PubMed  CAS  Google Scholar 

  2. Higgens CS, Keighley MRB, Allan RN. Impact of preopera-tive weight loss and body composition changes on postoperative outcome in surgery for inflammatory bowel disease. Gut 1984; 25: 732–6.

    Article  PubMed  CAS  Google Scholar 

  3. Brandes J-W, Korst HA, Littmann K-P. Sugar-free diet as a long term treatment or intermittent treatment during remission in Crohn’s disease–a prospective study. Leber Magen Darm 1982; 12: 225–8.

    PubMed  CAS  Google Scholar 

  4. Heaton KW, Thornton JR, Emmett PM. Treatment of Crohn’s disease with an unrefined-carbohydrate, fibre-rich diet. Brit Med J 1979; 279: 764–6.

    Article  Google Scholar 

  5. O’Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn’s disease: a controlled trial. Brit Med J 1984; 288: 1859–62.

    Article  Google Scholar 

  6. Meyers S, Walfish JS, Sachar DB, Greenstein AJ, Hill AG, Janowitz HD. Qualtiy of life after surgery for Crohn’s disease: a psychosocial survey. Gastroenterology 1980; 78: 1–6.

    PubMed  CAS  Google Scholar 

  7. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut 1984; 25: 665–72.

    Article  PubMed  CAS  Google Scholar 

  8. Makiyama K, Bennett MK, Jewell DP. Endoscopic appearances of the rectal mucosa of patients with Crohn’s disease visualized with a magnifying colonoscope. Gut 1984; 25: 337–40.

    Article  PubMed  CAS  Google Scholar 

  9. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH, Jr. Comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer 1981; 48: 2742–5.

    Article  PubMed  CAS  Google Scholar 

  10. Hamilton SR. Colorectal carcinoma in patients with Crohn’s disease. Gastroenterology 1985; 89: 398–407.

    PubMed  CAS  Google Scholar 

  11. Sachar DB, Greenstein AJ. Cancer in ulcerative colitis: good news and bad news (edit.). Ann Intern Med 1981; 95: 642–4.

    PubMed  CAS  Google Scholar 

  12. Gilat T, Zemishlany Z, Ribak J, Benaroya Y, Lilos P. Ulcerative colitis in the Jewish populations of Tel-Aviv Yafo. II: The rarity of malignant degeneration. Gastroen-terology 1974; 67: 933–8.

    CAS  Google Scholar 

  13. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis–based on results from a regional patient group from the country of Copenhagen. Gut 1985; 26: 158–63.

    Article  PubMed  CAS  Google Scholar 

  14. Katzka I, Brody R, Morris E, Katz S. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology 1983; 85: 22–9.

    PubMed  CAS  Google Scholar 

  15. Akwari O, van Heerden JA, Adson MA, Foulk WT, Bagenstoss AH. Bile duct carcinoma associated with ulcerative colitis. Rev Surg 1976; 33: 288–93.

    Google Scholar 

  16. Christophi C, Hughes ER. Hepatobiliary disorders in inflammatory bowel disease. Surg Gynecol Obstet 1985; 160: 187–93.

    PubMed  CAS  Google Scholar 

  17. Biarnason I, O’Morain C, Levi AJ, Peters TJ. Absorption of chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology 1983; 85: 318–22.

    Google Scholar 

  18. Meyers S, Wolke A, Field SP, Feuer EJ, Johnson JW, Janowitz HD. Fecal,-ant itryprin measurement: an indicator of Crohn’s disease activity. Gastroenterology 1985; 89: 13–8.

    PubMed  CAS  Google Scholar 

  19. de Dombai FT, Softley A. Observer variation in calculating indices of severity and activity in Crohn’s disease. 1986; submitted for publication

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Martinus Nijhoff Publishers

About this chapter

Cite this chapter

Sachar, D.B. (1986). Future Directions for Clinical Research. In: Rachmilewitz, D. (eds) Inflammatory Bowel Diseases 1986. Developments in Gastroenterology, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4269-1_30

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4269-1_30

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8396-6

  • Online ISBN: 978-94-009-4269-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics